Becton Dickinson (NYSE:BDX) hit a new 52-week high Friday as it is currently trading at $85.02, above its previous 52-week high of $85 with 241,535 shares traded as of 11:20 a.m. ET. Average volume has been one million shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Becton Dickinson (NYSE: BDX) hit a new 52-week high Friday as it is currently trading at $85.02, above its previous 52-week high of $85 with 241,535 shares traded as of 11:20 a.m. ET. Average volume has been one million shares over the past 30 days. Becton Dickinson has a market cap of $16.47 billion and is part of the health care sector and health services industry. Shares are up 7.6% year to date as of the close of trading on Thursday. Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. The company has a P/E ratio of 15.9, below the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations, increase in stock price during the past year, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. You can view the full Becton Dickinson Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.